Atovaquone 750 MG/5 ML susp 210ML
Ended Awarded
- Contract number
- SPE2DB25FJG83
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,727
Award facts
- Contract value 100% obligated
- $29,726.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Atovaquone 750 mg/5 mL suspension in a 210 mL quantity, valued at $29,726.50 under a firm fixed price contract type. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was not set aside and was competitively awarded, reflecting the company's established capability to meet federal pharmaceutical procurement requirements through open competition.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Atovaquone is an antiprotozoal medication commonly used in military and federal healthcare systems for treatment of conditions such as Pneumocystis pneumonia, and this delivery order reflects the ongoing pharmaceutical supply requirements of federal medical systems supported through the DLA's extensive medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FJG83?
SPE2DB25FJG83 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FJG83 worth?
The government has obligated $29,727 on SPE2DB25FJG83.
Is contract SPE2DB25FJG83 an order under another contract?
Yes. SPE2DB25FJG83 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJG83 competed?
The extent of competition for SPE2DB25FJG83 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award